Skip to main content

Table 4 Change in spirometry over time with respect to beta-blocker use

From: Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

Statcope

∆FEV1 in mL (SD)

∆ %FEV1 (SD)

∆ FVC in mL (SD)

∆ %FVC (SD)

 +BB (N = 54)

−13.1 (268.8)

0.33 (9.7)

−21.7 (382.9)

0.59 (10.2)

 −BB (N = 531)

−53.9 (241.3)

−1.24 (8.96)

−88.8 (444.4)

−1.43 (12)

P- value

0.29

0.25

0.23

0.18

Macro

  + BB (N = 96)

−13.9 (233.9)

−0.55 (8.61)

n/a

−0.52 (12.3)

 −BB (N = 381)

−12.7 (196)

−0.31 (6.5)

n/a

−0.47 (12.4)

P- value

0.96

0.76

 

0.97

  1. n/a not included as data reported for only 4 participants